Angus M. Sinclair
Corporate Officer/Principal at IGM BIOSCIENCES, INC.
Profile
Angus M.
Sinclair is currently the Senior Vice President-Immuno Oncology at IGM Biosciences, Inc. Prior to his current position, he worked as the Senior Director-Oncology Research at Northern Biologics, Inc. from 2015 to 2018.
Dr. Sinclair completed his undergraduate degree at The University of Edinburgh and obtained a doctorate from The National Institute For Medical Research.
Angus M. Sinclair active positions
Companies | Position | Start |
---|---|---|
IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 2017-12-31 |
Former positions of Angus M. Sinclair
Companies | Position | End |
---|---|---|
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 2017-12-31 |
Training of Angus M. Sinclair
The University of Edinburgh | Undergraduate Degree |
The National Institute For Medical Research | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IGM BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
- Stock Market
- Insiders
- Angus M. Sinclair